Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8543)
All Articles published online
|
Publishing Process of This Article
|
Jun 14, 2020 (publication date) through Apr 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Laursen TL, Sandahl TD, Kazankov K, George J, Grønbæk H. Liver-related effects of chronic hepatitis C antiviral treatment. World J Gastroenterol 2020; 26(22): 2931-2947 [PMID: 32587440 DOI: 10.3748/wjg.v26.i22.2931] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i22/2931.htm |
| Number | Citing Articles |
| 1 |
Apichat Kaewdech, Pimsiri Sripongpun, Natcha Cheewasereechon, Sawangpong Jandee, Naichaya Chamroonkul, Teerha Piratvisuth. Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma Patients. Clinical and Translational Gastroenterology 2021; 12(2): e00310 doi: 10.14309/ctg.0000000000000310
|
| 2 |
Sara Cuesta-Sancho, Mercedes Márquez-Coello, Francisco Illanes-Álvarez, Denisse Márquez-Ruiz, Ana Arizcorreta, Fátima Galán-Sánchez, Natalia Montiel, Manuel Rodriguez-Iglesias, José-Antonio Girón-González. Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response. World Journal of Hepatology 2022; 14(1): 62-79 doi: 10.4254/wjh.v14.i1.62
|
| 3 |
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatment. World Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
|
| 4 |
Cristina Maria Marginean, Denisa Pirscoveanu, Mihaela Popescu, Corina Maria Vasile, Anca Oana Docea, Radu Mitruț, Iulia Cristina Mărginean, George Alexandru Iacob, Dan Mihai Firu, Paul Mitruț. Challenges in Diagnosis and Therapeutic Approach of Acute on Chronic Liver Failure—A Review of Current Evidence. Biomedicines 2023; 11(7): 1840 doi: 10.3390/biomedicines11071840
|
| 5 |
Sabine Gufler, Rita Seeboeck, Christoph Schatz, Johannes Haybaeck. The Translational Bridge between Inflammation and Hepatocarcinogenesis. Cells 2022; 11(3): 533 doi: 10.3390/cells11030533
|
| 6 |
Carlo Smirne, Maria Grazia Crobu, Irene Landi, Nicole Vercellino, Daria Apostolo, David James Pinato, Federica Vincenzi, Rosalba Minisini, Stelvio Tonello, Davide D’Onghia, Antonio Ottobrelli, Silvia Martini, Christian Bracco, Luigi Maria Fenoglio, Mauro Campanini, Alessandro Maria Berton, Alessia Ciancio, Mario Pirisi. Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?. Viruses 2024; 16(12): 1899 doi: 10.3390/v16121899
|
| 7 |
A. Romano, N. Zeni, A. R. Caspanello, S. Phillips, S. S. Piano, P. Angeli. Follow‐up post‐HCV virological response to DAA in advanced chronic liver disease. Liver International 2024; 44(12): 3138 doi: 10.1111/liv.16113
|
| 8 |
Yasmeen Ishaq, Bisma Rauff, Badr Alzahrani, Aqsa Ikram, Hasnain Javed, Imran Abdullah, Ghulam Mujtaba. Bioinformatics and Experimental Insights Into miR‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for HCV‐Associated HCC. Cancer Reports 2024; 7(12) doi: 10.1002/cnr2.70049
|
| 9 |
Cristina Maria Muzica, Carol Stanciu, Cristina Cijevschi-Prelipcean, Irina Girleanu, Laura Huiban, Oana Cristina Petrea, Ana-Maria Singeap, Camelia Cojocariu, Tudor Cuciureanu, Catalin Sfarti, Sebastian Zenovia, Stefan Chriac, Gabriela Stefanescu, Irina Ciortescu, Corina Lupașcu-Ursulescu, Egidia Miftode, Anca Trifan. Long-term Risk of Hepatocellular Carcinoma Following Direct-Acting Antiviral Therapy in Compensated Liver Cirrhosis Induced by Hepatitis C Virus Infection. Hepatitis Monthly 2021; 21(6) doi: 10.5812/hepatmon.115910
|
| 10 |
Virginia Solitano, Maria Corina Plaz Torres, Nicola Pugliese, Alessio Aghemo. Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?. Viruses 2021; 13(6): 1048 doi: 10.3390/v13061048
|
| 11 |
E. S. Pak, R. V. Korobka, V. D. Pasechnikov, M. Yu. Kostrykin, O. V. Bukhtin, A. V. Mikutin, A. M. Shapovalov, A. B. Lageza, G. V. Novikova, D. V. Pasechnikov, V. S. Agabekyan. Results of regional care for patients with cirrhosis of the liver in the outcome of viral hepatitis C in the era of direct-acting antiviral drugs. South Russian Journal of Therapeutic Practice 2024; 5(4): 90 doi: 10.21886/2712-8156-2024-5-4-90-98
|
| 12 |
Nermine Magdi Riad, Heba Adel AbdEl Ghaffar, Reem Raied Mansour, Walaa Abdel Fattah, Ahmed Khairy, Ayman Yosry, Naglaa Ali Zayed, Mariam Onsy F. Hanna. Clinical Significance of Evaluation of Monocytic Receptors in Patients with Hepatitis C Virus Infection. Viral Immunology 2023; 36(7): 475 doi: 10.1089/vim.2022.0180
|
| 13 |
Yasmeen Ishaq, Bisma Rauff, Badr Alzahrani, Hassnain Javed, Aqsa Ikram. Identification of Serum‐Derived CricRNA Diagnostic Panel and Revealing Their Regulatory Mechanisms in HCV‐HCC: A Cross‐Sectional Study. Health Science Reports 2024; 7(12) doi: 10.1002/hsr2.70282
|
| 14 |
Shinya Maekawa, Shinichi Takano, Nobuyuki Enomoto. Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment. Journal of the Formosan Medical Association 2024; 123(11): 1124 doi: 10.1016/j.jfma.2024.01.015
|